Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section
NCT ID: NCT04095013
Last Updated: 2019-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-02-01
2019-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bupivacaine Alone vs Bupivacaine and Dexmed in Cesarean Deliveries
NCT05469529
Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section
NCT03775655
Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.
NCT06942000
Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section
NCT02365857
Sequential Intrathecal Injection of Fentanyl and Hyperbaric Bupivacaine
NCT03415087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group BF
hyperbaric Bupivacaine 10mg with fentanyl 10micrograms
Bupivacaine, fentanyl
Group A: hyperbaric Bupivacaine 10mg with fentanyl 10micrograms,
Group BD
hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms
Bupivacaine, dexmedetomidine
Group B: hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine, fentanyl
Group A: hyperbaric Bupivacaine 10mg with fentanyl 10micrograms,
Bupivacaine, dexmedetomidine
Group B: hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sana Urooj
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Civil Hospital Karachi
Karachi, Sindh, Pakistan
DUHS, Civil hospital Karachi (CHK)
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.